Tag: heart disease

The National Institutes of Health (NIH) has officially announced a $21 million funding injection to establish a groundbreaking research program dedicated to the development of sophisticated computer-based simulations. This program, titled the Computational Modeling of Hormone Homeostasis Initiative, aims to revolutionize the understanding of hormone homeostasis—the complex, self-regulating processes by which the human body maintains…

Researchers presenting at ENDO 2026, the Endocrine Society’s annual meeting in Chicago, have unveiled startling data regarding the presence of endocrine-disrupting chemicals (EDCs) in both breast milk and the urine of infants during the first six months of life. The study, led by Maria Elisabeth Street, MD, PhD, associate professor and director of the Division…

The landscape of endocrine oncology is undergoing a transformative period characterized by the development of novel diagnostic algorithms, the discovery of rare clinical phenomena, and a renewed focus on the continuity of patient care. Cancer remains a ubiquitous challenge that transcends professional boundaries, affecting clinicians, researchers, and families alike. In response to these challenges, the…

The landscape of modern biomedical research is often defined by its breakthroughs, yet the underlying reality for many scientists is a persistent cycle of trial, error, and professional setback. At the ENDO 2026 conference in Chicago, a gathering of the world’s leading endocrinologists and researchers, this often-ignored aspect of the scientific vocation took center stage.…

The field of endocrinology often resembles a high-stakes detective novel, where clinicians must look beyond obvious symptoms to uncover hidden physiological interactions. A remarkable case recently highlighted at the ENDO 2026 conference in Chicago exemplifies this complexity, detailing how one rare endocrine tumor effectively acted as a "natural treatment" for another. The case, originally published…

A recent clinical report published in JCEM Case Reports has brought to light a significant diagnostic oversight that led to life-altering surgical intervention and a subsequent life-threatening medical emergency. Researchers in Brazil documented the case of a 22-year-old male who, after undergoing a bilateral radical orchiectomy for suspected testicular cancer, fell into an acute adrenal…

The National Institutes of Health (NIH) has announced a significant investment in the future of precision medicine, awarding an initial $4.6 million to a collaborative team of researchers led by Michigan State University (MSU). This funding represents the first installment of a larger grant totaling up to $12.8 million over three years, aimed at developing…

On September 29, a coalition of the nation’s leading medical societies and health advocacy groups converged on Capitol Hill to issue a unified call for a transformative shift in the American healthcare landscape. Representing the Endocrine Society, the Society for Women’s Health Research (SWHR), the American College of Obstetricians and Gynecologists (ACOG), and the Women…

The selection of Zerihun Haile-Selassie, CAE, as a 2026 Nonprofit CFO of the Year marks a significant milestone for the Endocrine Society and the broader association management community. Recognized specifically in the category of CFO of a Large Nonprofit Association, Haile-Selassie’s honors stem from a career-long dedication to operational excellence, innovative financial management, and a…

The United States Food and Drug Administration (FDA) has granted approval to KERENDIA® (finerenone) for the treatment of chronic kidney disease (CKD) associated with type 1 diabetes (T1D). This landmark decision, announced by Bayer on September 17, marks the first time in over three decades that a new pharmacological intervention has been approved to specifically…